Strauss Controlling Shareholder Ofra Strauss to Join Top-Gum Board
Translated & summarized from Calcalist by baba
Ofra Strauss, controlling shareholder of the Israeli food giant Strauss, will unusually join the board of dietary supplement company Top-Gum. Top-Gum, valued at 1.15 billion shekels, has seen significant growth with record revenues and expanding global operations. Strauss's connection to Sderot, where Top-Gum also operates, is cited as a factor in the appointment. The move is uncommon for major shareholders who typically focus on their own companies.
The story in 5 lines · by baba
- Ofra Strauss, controlling shareholder of Strauss, will join the board of Top-Gum.
- The appointment is considered unusual for a major shareholder of a large company.
- Top-Gum specializes in vitamins and dietary supplements and is valued at 1.15 billion shekels.
- Top-Gum has reported ten consecutive record quarters with significant revenue growth.
- Strauss also has operational ties to Sderot, where Top-Gum originated.
Ofra Strauss, the controlling shareholder of the food company Strauss, is set to be appointed to the board of directors of Top-Gum, a company specializing in vitamins and dietary supplements. This appointment is considered unusual, as major shareholders typically focus solely on their own companies, especially those with a market capitalization like Strauss, valued at 13 billion shekels. Top-Gum, which has a market value of 1.15 billion shekels and is traded on the Tel Aviv Stock Exchange, develops and manufactures gummy vitamin and supplement products for major brands globally. The company, which began its operations in Sderot, Israel, also has production sites in Canada and the United States, employing over 400 people. Strauss's decision to join Top-Gum's board is reportedly influenced by the fact that Strauss also has operations in Sderot, where its salted snack factory is located, despite its main base being in Nahariya. Top-Gum's chairman is Raveev Tsofer, former CEO of ICL and current chairman of Migdal Insurance. Top-Gum has experienced significant growth, reporting its tenth consecutive record quarter in Q2 2026 with revenues of approximately $33.8 million, a 50% organic growth. For the first half of 2026, the group's revenues reached about $65.7 million, a 65% increase, with a record order backlog of $57 million in the dietary supplement sector. The company anticipates exceeding $145 million in annual sales by the second half of 2026. Top-Gum also recently expanded its operations by acquiring a gummy production facility in the U.S. in May 2026 and a Canadian operation in 2025.